Results 31 to 40 of about 897 (146)

Az elhízás és cukorbetegség kezelésére alkalmas új molekuláris targetek meghatározása és validálása = Identification and validation of novel molecular target for obesity and type 2 diabetes [PDF]

open access: yes, 2012
A kutatási tervben megfogalmazott programunk elsődleges célja az volt, hogy korunk népbetegségének számító elhízás, metabolikus szindróma és 2-es típusú cukorbetegség kialakulásában szerepet játszó élettani és kórélettani mechanizmusokat feltárjuk ...
Hegedűs, Csaba   +8 more
core  

Comparison of polypharmacy in schizophrenia and other psychotic disorders in outpatient and inpatient treatment periods: a naturalistic one year follow-up study

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: Polypharmacy of antipsychotic drugs has been increasing although there are not enough evidence based data and recommendations in the treatment algorithms.
Hasan Karadag   +6 more
doaj   +1 more source

Analisis Efektivitas Biaya dan Terapi Antipsikotik Haloperidol-Klorpromazin dan Risperidon-Klozapin pada Pasien Skizofrenia [PDF]

open access: yes, 2017
Penggunaan jangka panjang terapi antipsikotik merupakan beban biaya yang ditanggung pasien skizofrenia. Penelitian ini bertujuan untuk mengetahui perbedaan efektivitas biaya dan efektivitas terapi kombinasi oral haloperidol-klorpromazin (tipikal ...
Aryani, F. (Fina)   +4 more
core  

Neuropsychological assessment in schizophrenic patients treated with haloperidol or clozapine

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Objective: The purpose of this study was to examine whether there are differences between two schizophrenic patient groups treated with haloperidol or clozapine, on measures of cognitive functions.
Serhat Çıtak   +2 more
doaj  

Metabolic and Endocrine Side Effects of Atypical Antipsychotic Drugs in Children and Adolescents [PDF]

open access: yes, 2011
omorbid psychiatric disorders, frequent hospitalization, multiple outpatient treatment, prior history of hypertension, obesity and lipid dysregulation are associated with higher risk of metabolic syndrome in children.
Ayse Avci   +2 more
core  

Seizure associated with olanzapine: case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Although it is well known that antipsychotic drugs can lower the seizure threshold, the traditional antipsychotic drugs usually do not substantially affect seizure risk.
Gülcan Güleç, Rukiye Yasemin Kılıç
doaj  

Hyperprolactinemia due to paliperidone palmitate and treatment with aripiprazole

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
For all typical antipsychotics, potent D2 receptor antagonism and prolonged connection to the receptor causes increased secretion of prolactin. Among second-generation antipsychotics, risperidone and amisulpride increase prolactin levels similar to ...
Gokay Alpak   +5 more
doaj   +1 more source

Addition of aripiprazole to the clozapine: A case report

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
About one third of patients with schizophrenia respond unsatisfactorily to antipsychotic treatment. Clozapine is still the gold standard in these cases.But, inadequate response to clozapine poses a substantial problem in the pharmaco-therapy of ...
Meltem Puşuroğlu   +5 more
doaj  

Identifikasi Drug Related Problems (Drps) Potensial Pada Pasien Asma Di Instalasi Rawat Inap Rsud Dr. Moewardi Tahun 2015 [PDF]

open access: yes, 2017
Asthma is a public health problem in almost all countries in the world. Potential drug related problems (DRPs) contribute to morbidity and mortality in asthmatic atients.
, Dra. Nurul Mutmainah, M.Si., Apt   +1 more
core  

ATYPICAL ANTIPSYCHOTIC CONCEPT AND NEW HORIZONS IN DRUG TREATMENT OF SCHIZOPHRENIA

open access: yesPsychiatry and Clinical Psychopharmacology, 2021
Conventional antipsychotic agents are known as neuroleptics, and these drugs block dopamine-2 receptors in the mesolimbic dopamine pathway in order to reduce positive symptoms of schizophrenia.
Işık TUĞLULAR
doaj  

Home - About - Disclaimer - Privacy